Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
325.60    -5.00 (-1.51%)
Bid:
325.60
Ask:
326.00
Spread: 0.40 (0.123%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim 2020 Dividend/Enhanced Script Correction

16 Dec 2020 12:00

RNS Number : 8736I
Hammerson PLC
16 December 2020
 

Hammerson plc (the 'Company')

16 December 2020

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative - Correction

 

The following amendment has been made to the Interim 2020 Dividend and Enhanced Scrip Dividend Alternative announcement released on 8 December 2020 at 13:15 under RNS No 9480H.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, rather than 189,816,827 New Shares admitted to trading on the London Stock Exchange and 36,013,297 New Shares admitted to trading on the Johannesburg Stock Exchange, as stated in the main body of the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Hammerson plc

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

 

16 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange. Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholderinformation/general-meeting.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKKABBDBDDPBD
Date   Source Headline
20th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 202210:00 amRNSBlock listing Interim Review
31st May 20224:50 pmRNSDirector/PDMR Shareholding
18th May 20224:30 pmRNSPurchase of Shares by the Employee Benefit Trust
17th May 202211:00 amRNSDirector/PDMR Shareholding
13th May 20224:50 pmRNSDirector/PDMR Shareholding
11th May 20224:30 pmRNSDirector/PDMR Shareholding
10th May 20224:30 pmRNSHolding(s) in Company
10th May 20229:00 amRNSTotal Voting Rights and Capital
5th May 20227:00 amRNSFinal Dividend and Enhanced Scrip Alternative
28th Apr 20224:15 pmRNSHolding(s) in Company
28th Apr 20223:30 pmRNSResult of AGM
26th Apr 20224:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202211:45 amRNSHolding(s) in Company
8th Apr 20223:30 pmRNSDirector/PDMR Shareholding
7th Apr 20221:00 pmRNSHolding(s) in Company
4th Apr 202211:00 amRNSHolding(s) in Company
1st Apr 202211:00 amRNSHolding(s) in Company
31st Mar 20221:00 pmRNSDirector Declaration
31st Mar 20229:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Mar 202212:00 pmRNSHolding(s) in Company
28th Mar 202211:30 amRNSHolding(s) in Company
24th Mar 202212:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20222:00 pmRNSAnnual Report, Notice of AGM and Scrip Circular
23rd Mar 202211:00 amRNSDirector/PDMR Shareholding
22nd Mar 20221:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20229:00 amRNSCurrency Conversion & Scrip Reference Share Price
18th Mar 202211:15 amRNSHolding(s) in Company
17th Mar 202211:00 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSCompletion of Silverburn disposal
15th Mar 20222:00 pmRNSHolding(s) in Company
14th Mar 20223:30 pmRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
4th Mar 20227:01 amRNSDividend Declaration
4th Mar 20227:01 amRNSDirectorate Change
4th Mar 20227:00 amRNSFinal Results
25th Feb 202211:30 amRNSDisposal of non-core assets
22nd Feb 20222:30 pmRNSDirectorate Change
21st Feb 202212:00 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSResponse to Press Speculation
15th Feb 202211:00 amRNSHolding(s) in Company
4th Feb 20229:00 amRNSNotification of 2021 Full Year Results
27th Jan 20227:00 amRNSTrading, operational and rent collection update
14th Jan 202211:15 amRNSHolding(s) in Company
13th Jan 20229:00 amRNSHolding(s) in Company
5th Jan 20229:00 amRNSHolding(s) in Company
4th Jan 20223:45 pmRNSTotal Voting Rights and Capital
4th Jan 202211:45 amRNSHolding(s) in Company
23rd Dec 20213:45 pmRNSDirector/PDMR Shareholding
23rd Dec 202111:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.